Octapharma

Octapharma, headquartered in Lachen, Switzerland, is a leading global human protein manufacturer with a strong commitment to advancing human life through innovative health solutions. With a workforce of nearly 12,000 individuals, Octapharma operates in 118 countries, offering products spanning the areas of Immunotherapy, Haematology, and Critical Care. The company boasts seven R&D sites and five cutting-edge manufacturing facilities in Austria, France, Germany, and Sweden. Additionally, it runs more than 195 plasma donation centres across Europe and the US, with a noteworthy 40-year track record in patient care. Octapharma's dedication to research and development, as well as its global presence, positions it as a significant player in the healthcare industry. The company's commitment to patient care and its extensive reach make it an attractive potential investment opportunity for venture capitalists seeking to support advancements in global health solutions.